• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于血液的全基因组DNA甲基化与静脉血栓栓塞之间的关联

The Association between Blood-Based Global DNA Methylation and Venous Thromboembolism.

作者信息

Wang Xiao, Memon Ashfaque A, Palmér Karolina, Svensson Peter J, Sundquist Jan, Sundquist Kristina

机构信息

Center for Primary Health Care Research, Lund University, Malmö, Sweden.

Department of Coagulation Disorders, Lund University Hospital, Malmö, Sweden.

出版信息

Semin Thromb Hemost. 2021 Sep;47(6):662-668. doi: 10.1055/s-0040-1722271. Epub 2020 Dec 30.

DOI:10.1055/s-0040-1722271
PMID:33378784
Abstract

Alterations in DNA methylation patterns have been associated with many diseases. However, the role of DNA methylation in venous thromboembolism (VTE) is not well established. The aim of this study was to investigate a possible association between global DNA methylation and VTE. The study participants consisted of 168 individuals including 74 patients with primary VTE from the Malmö Thrombophilia Study (MATS) and 94 healthy controls. Among 74 primary VTE patients, 37 suffered VTE recurrence during the follow-up period; 37 nonrecurrent VTE patients were included for comparison. Blood-based global DNA methylation was assessed by an enzyme-linked immunosorbent assay. Global DNA methylation was significantly higher in primary VTE patients compared with the healthy controls (median: 0.17 vs. 0.08%;  < 0.001). After stratification of data from primary VTE patients according to sex, the association between higher global DNA methylation and shorter recurrence-free survival time was of borderline statistical significance in males ( = -0.2;  = 0.052) but not in females ( = 0.02;  = 0.90). Our results show that global DNA methylation is associated with primary VTE and that higher levels of global DNA methylation may be associated with early VTE recurrence in males but not in females. Further investigation on the role of DNA methylation as a diagnostic or preventive biomarker in VTE is warranted.

摘要

DNA甲基化模式的改变与许多疾病有关。然而,DNA甲基化在静脉血栓栓塞症(VTE)中的作用尚未明确。本研究的目的是调查整体DNA甲基化与VTE之间可能存在的关联。研究参与者包括168名个体,其中有来自马尔默血栓形成倾向研究(MATS)的74例原发性VTE患者和94名健康对照者。在74例原发性VTE患者中,37例在随访期间出现VTE复发;纳入37例未复发的VTE患者作为对照。采用酶联免疫吸附测定法评估基于血液的整体DNA甲基化。原发性VTE患者的整体DNA甲基化水平显著高于健康对照者(中位数:0.17%对0.08%;<0.001)。根据性别对原发性VTE患者的数据进行分层后,整体DNA甲基化水平较高与男性无复发生存时间较短之间的关联具有临界统计学意义(=-0.2;=0.052),而在女性中无此关联(=0.02;=0.90)。我们的结果表明,整体DNA甲基化与原发性VTE相关,并且较高水平的整体DNA甲基化可能与男性早期VTE复发有关,而与女性无关。有必要进一步研究DNA甲基化作为VTE诊断或预防生物标志物的作用。

相似文献

1
The Association between Blood-Based Global DNA Methylation and Venous Thromboembolism.基于血液的全基因组DNA甲基化与静脉血栓栓塞之间的关联
Semin Thromb Hemost. 2021 Sep;47(6):662-668. doi: 10.1055/s-0040-1722271. Epub 2020 Dec 30.
2
Risk prediction of recurrent venous thromboembolism: a multiple genetic risk model.复发性静脉血栓栓塞风险预测:多基因风险模型。
J Thromb Thrombolysis. 2019 Feb;47(2):216-226. doi: 10.1007/s11239-018-1762-7.
3
Fat mass and obesity-associated gene rs9939609 polymorphism is a potential biomarker of recurrent venous thromboembolism in male but not in female patients.脂肪量和肥胖相关基因rs9939609多态性是男性复发性静脉血栓栓塞的潜在生物标志物,而在女性患者中并非如此。
Gene. 2018 Mar 20;647:136-142. doi: 10.1016/j.gene.2018.01.013. Epub 2018 Jan 9.
4
Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.杂合子和纯合子因子 V 莱顿突变携带者之间的静脉血栓栓塞事件和复发风险是否真的不同?一项回顾性队列研究。
Eur J Intern Med. 2016 May;30:77-81. doi: 10.1016/j.ejim.2016.02.023. Epub 2016 Mar 9.
5
Transforming growth factor (TGF)-β levels and unprovoked recurrent venous thromboembolism.转化生长因子(TGF)-β水平与不明原因复发性静脉血栓栓塞症
J Thromb Thrombolysis. 2014 Oct;38(3):348-54. doi: 10.1007/s11239-013-1047-0.
6
Association between TLR9 rs5743836 polymorphism and risk of recurrent venous thromboembolism.Toll样受体9基因rs5743836多态性与复发性静脉血栓栓塞风险的关联
J Thromb Thrombolysis. 2017 Jul;44(1):130-138. doi: 10.1007/s11239-017-1491-3.
7
Apolipoprotein M and the risk of unprovoked recurrent venous thromboembolism.载脂蛋白 M 与无诱因复发性静脉血栓栓塞风险。
Thromb Res. 2014 Mar;133(3):322-6. doi: 10.1016/j.thromres.2013.12.006. Epub 2013 Dec 10.
8
Clinical implications of different risk factor profiles in patients with mesenteric venous thrombosis and systemic venous thromboembolism: a population-based study.肠系膜静脉血栓形成和全身性静脉血栓栓塞症患者不同危险因素特征的临床意义:一项基于人群的研究。
J Thromb Thrombolysis. 2019 May;47(4):572-577. doi: 10.1007/s11239-019-01816-x.
9
Identification of polymorphisms in Apolipoprotein M gene and their relationship with risk of recurrent venous thromboembolism.载脂蛋白M基因多态性的鉴定及其与复发性静脉血栓栓塞风险的关系。
Thromb Haemost. 2016 Aug 30;116(3):432-41. doi: 10.1160/TH16-03-0178. Epub 2016 Jun 9.
10
Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner.PARK2 和 MRPL37 中的多态性与复发性静脉血栓栓塞的风险增加相关,且具有性别特异性。
J Thromb Thrombolysis. 2018 Aug;46(2):154-165. doi: 10.1007/s11239-018-1662-x.

引用本文的文献

1
Comparison of DNA Methylation Changes Between the Gestation Period and the After-Delivery State: A Pilot Study of 10 Women.妊娠期与产后状态之间DNA甲基化变化的比较:一项针对10名女性的初步研究。
Front Nutr. 2022 May 4;9:829915. doi: 10.3389/fnut.2022.829915. eCollection 2022.